ursolic acid has been researched along with Non-alcoholic Fatty Liver Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Huang, C; Liu, F; Zhao, L; Zheng, Y | 1 |
| Chivandi, E; Dangarembizi, R; Erlwanger, KH; Mukonowenzou, NC; Nkomozepi, P | 1 |
| Chang, HY; Chen, CJ; Cheng, WK; Chu, FY; Hsu, YA; Lim, YP; Lin, YN; Ma, WC; Wan, L; Wang, CCN | 1 |
| Guo, F; Li, S; Li, X; Li, Y; Liao, X; Meng, F; Meng, M; Sun, C; Sun, Z; Wang, Y | 1 |
| Li, JS; Sun, Y; Wang, WJ; Zhang, YH; Zheng, L | 1 |
| He, P; Lei, JH; Wang, CX; Yuan, WG; Zhang, CY | 1 |
1 review(s) available for ursolic acid and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets.
Topics: Acetyl-CoA C-Acetyltransferase; Animals; CD4-Positive T-Lymphocytes; Disease Progression; Fatty Liver, Alcoholic; Hepatic Stellate Cells; Humans; Interleukins; Intracellular Signaling Peptides and Proteins; LIM Domain Proteins; Liver Cirrhosis; Macrophages; MicroRNAs; Molecular Targeted Therapy; Non-alcoholic Fatty Liver Disease; Resveratrol; Schistosomiasis; Signal Transduction; Stilbenes; T-Lymphocytes, Regulatory; Triterpenes; Ursodeoxycholic Acid; Ursolic Acid; Virus Diseases | 2016 |
5 other study(ies) available for ursolic acid and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Regulation of decorin by ursolic acid protects against non-alcoholic steatohepatitis.
Topics: Animals; Cell Hypoxia; Cells, Cultured; Computational Biology; Databases, Genetic; Decorin; Disease Models, Animal; Gene Expression Regulation; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Liver; Male; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Receptor, IGF Type 1; Signal Transduction; Triterpenes; Ursolic Acid | 2021 |
Administration of ursolic acid to new-born pups prevents dietary fructose-induced non-alcoholic fatty liver disease in Sprague Dawley rats.
Topics: Adiposity; Animals; Dietary Carbohydrates; Disease Models, Animal; Female; Fructose; Humans; Liver; Male; Non-alcoholic Fatty Liver Disease; Protective Agents; Rats; Rats, Sprague-Dawley; Sex Factors; Triterpenes; Ursolic Acid; Weaning | 2021 |
Ursolic Acid, a Novel Liver X Receptor α (LXRα) Antagonist Inhibiting Ligand-Induced Nonalcoholic Fatty Liver and Drug-Induced Lipogenesis.
Topics: Animals; Basic-Leucine Zipper Transcription Factors; Humans; Hydrocarbons, Fluorinated; Ligands; Lipogenesis; Liver; Liver X Receptors; Male; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Non-alcoholic Fatty Liver Disease; Sterol Regulatory Element Binding Protein 1; Sulfonamides; Triterpenes; Ursolic Acid | 2018 |
Therapeutic role of ursolic acid on ameliorating hepatic steatosis and improving metabolic disorders in high-fat diet-induced non-alcoholic fatty liver disease rats.
Topics: Animals; CD36 Antigens; Diacylglycerol O-Acyltransferase; Diet, High-Fat; Dietary Fats; Fatty Liver; Gene Expression; Insulin Resistance; Lipase; Lipid Metabolism; Liver; Male; Non-alcoholic Fatty Liver Disease; Obesity; PPAR alpha; Rats; Rats, Sprague-Dawley; RNA, Messenger; RNA, Small Interfering; Triterpenes; Ursolic Acid | 2014 |
Ursolic acid inhibits the development of nonalcoholic fatty liver disease by attenuating endoplasmic reticulum stress.
Topics: Animals; Endoplasmic Reticulum Stress; Female; Humans; Lipid Metabolism; Liver; Male; Mice; Non-alcoholic Fatty Liver Disease; Reactive Oxygen Species; Triterpenes; Ursolic Acid | 2015 |